The goal of this clinical trial is to evaluate the safety and effectiveness of a poly-L-lactic acid (PLLA) dermal implant for the correction of nasolabial folds. The study also aims to determine whether the investigational product (FUYANMEI Poly-L-Lactic Acid) is non-inferior to the control product (Sculptra). The main questions it aims to answer are: * Is the effectiveness rate based on the Wrinkle Severity Rating Scale (WSRS) at 6 months after injection for the investigational group non-inferior to that of the control group? * How does the investigational product perform in terms of global aesthetic improvement as assessed by blinded evaluators and by subjects? * What is the safety profile of the investigational product, including the incidence, severity, and relatedness of adverse events (AEs), serious adverse events (SAEs), and device deficiencies (DDs)? Researchers will compare the investigational PLLA implant to an approved PLLA implant using a prospective, randomized, evaluator- and subject-blinded, single-center, split-face controlled study design. Approximately 121 eligible participants will be enrolled. Participants will: * Receive treatment with the investigational product and the control product according to the split-face design * Be followed for 24 months after injection * Return to the clinic at 1, 3, 6, 12, 18, and 24 months post-injection for follow-up visits * Undergo blinded evaluator assessments of WSRS and Global Aesthetic Improvement Scale (GAIS) * Complete subject self-assessments of GAIS and treatment satisfaction * Be monitored throughout the study for adverse events, serious adverse events, and medical device deficiencies
Age range
19 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
The responder rate based on the Wrinkle Severity Rating Scale (WSRS).
Timeframe: at Month 6 post-injection